Loading…
Intas Pharmaceuticals Ltd. is a multinational pharmaceutical company specializing in formulation development, manufacturing, and marketing of generics, oncology, parenterals, and biosimilars. Trusted in over 85 countries, it generates about 70% of its revenue from international markets, including the EU and US.
AI named Intas Pharma from December 2025 to February 2026.